Literature DB >> 24778392

Nodular Regenerative Hyperplasia After Treatment With Trastuzumab Emtansine.

Jeremy Force1, Romil Saxena1, Bryan P Schneider1, Anna M Storniolo1, George W Sledge1, Naga Chalasani1, Raj Vuppalanchi2.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2014        PMID： 24778392     DOI： 10.1200/JCO.2013.49.8543

Source DB:  PubMed          Journal:  J Clin Oncol        ISSN： 0732-183X            Impact factor:   44.544


× No keyword cloud information.
  3 in total

1.  Splenic Enlargement and Bone Marrow Hyperplasia in Patients Receiving Trastuzumab-Emtansine for Metastatic Breast Cancer.

Authors:  Michael Kosmin; Andreas Makris; Noorulhuda Jawad; David Woolf; David Miles; Anwar R Padhani
Journal:  Target Oncol       Date:  2017-04       Impact factor: 4.493

2.  Sinusoidal obstruction syndrome post-treatment with trastuzumab emtansine (T-DM1) in advanced breast cancer.

Authors:  Yasutoshi Fujii; Mihoko Doi; Naofumi Tsukiyama; Yui Hattori; Kazuki Ohya; Noriyuki Shiroma; Kei Morio; Takehiko Morioka; Hiroshi Aikata; Katsunori Shinozaki; Kazuaki Chayama
Journal:  Int Cancer Conf J       Date:  2019-10-24

3.  Diagnosing Nodular Regenerative Hyperplasia of the Liver Is Thwarted by Low Interobserver Agreement.

Authors:  Bindia Jharap; Dirk P van Asseldonk; Nanne K H de Boer; Pierre Bedossa; Joachim Diebold; A Mieke Jonker; Emmanuelle Leteurtre; Joanne Verheij; Dominique Wendum; Fritz Wrba; Pieter E Zondervan; Jean-Frédéric Colombel; Walter Reinisch; Chris J J Mulder; Elisabeth Bloemena; Adriaan A van Bodegraven
Journal:  PLoS One       Date:  2015-06-08       Impact factor: 3.240
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.